Skip to main content
Retour
Watch Compare

Cardio Diagnostics Holdings, Inc.

Qualité des données : 100%
Également cotée sous CDIOW Nasdaq
CDIO
Nasdaq Manufacturing Chemicals
1,81 €
▼ 0,22 € (-10,84%)
Cap. Boursière: 5,36 M
Prix
1,81 €
Cap. Boursière
5,36 M
Fourchette du Jour
1,80 € — 2,08 €
Fourchette 52 Semaines
0,97 € — 17,40 €
Volume
163 907
Ouverture 2,08 €
Moyenne 50J / 200J
2,70 €
32,92% below
Moyenne 50J / 200J
3,40 €
46,73% below

Quick Summary

Points Clés

Negative free cash flow of -5,91 M
Capital intensive — 1263,52% of revenue goes to capex

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)-57,51%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-72,70%
En dessous de la moyenne du secteur (-53,41%)
ROIC-55,63%
Net Margin-43832,49%
Op. Margin-43737,46%

Sécurité

Debt / Equity
N/A
Current Ratio17,39
Interest Coverage-438,08

Valorisation

PE (TTM)
-0,82
Au-dessus de la moyenne du secteur (-1,48)
P/B Ratio0,66
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -0,8 -1,5
P/B 0,7 1,6
ROE % -72,7 -53,4
Net Margin % -43832,5 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -57,51% Revenue Growth (3Y) -6,79%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 14 825,0 Net Income (TTM) -6,50 M
ROE -72,70% ROA -67,74%
Gross Margin N/A Operating Margin -43737,46%
Net Margin -43832,49% Free Cash Flow (TTM) -5,91 M
ROIC -55,63% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 17,39
Interest Coverage -438,08 Asset Turnover 0,00
Working Capital 6,53 M Tangible Book Value 8,15 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,82 Forward P/E N/A
P/B Ratio 0,66 P/S Ratio 361,32
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -110,41%
Market Cap 5,36 M Enterprise Value 5,36 M
Per Share
EPS (Diluted TTM) -3,71 Revenue / Share 0,01
FCF / Share -2,00 OCF / Share -1,94
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1263,52% FCF Conversion 91,01%
SBC-Adj. FCF -6,02 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2022
Revenue 14 825,0 34 890,0 17 065,0 — 950,0
Net Income -6,50 M -8,38 M -8,38 M -144 837,0 -4,66 M
EPS (Diluted) -3,71 -0,31 -0,66 — -1,51
Gross Profit — — — — —
Operating Income -6,48 M -8,37 M -7,24 M -145 321,0 -4,55 M
EBITDA — — — — —
R&D Expenses 641 212,0 29 125,0 145 182,0 — 40 448,0
SG&A Expenses — — — — —
D&A 65 233,0 19 738,0 19 182,0 — 16 000,0
Interest Expense 14 801,0 18 640,0 6,74 M — —
Income Tax — — — — 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2022
Total Assets 7,77 M 10,62 M 4,46 M 65,81 M 6,25 M
Total Liabilities 793 061,0 1,06 M 1,50 M 124 434,0 1,95 M
Shareholders' Equity 6,97 M 9,56 M 2,96 M 682 732,0 4,30 M
Total Debt — — — — —
Cash & Equivalents 0,0 0,0 0,0 0,0 0,0
Current Assets 5,92 M 8,79 M 2,77 M 806 682,0 5,89 M
Current Liabilities 604 839,0 631 695,0 841 142,0 124 434,0 —